4//SEC Filing
Vivo Opportunity, LLC 4
Accession 0001213900-23-065297
CIK 0001865494other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 9:03 AM ET
Size
14.6 KB
Accession
0001213900-23-065297
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Vivo Capital IX, LLC
10% Owner
Transactions
- Purchase
Warrants (Right to Buy)
2023-08-09$0.13/sh+3,157,894$394,737→ 3,157,894 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)Exercise: $2.47From: 2023-08-09→ Common Stock (3,157,894 underlying) - Purchase
Common Stock
2023-08-09$1.90/sh+3,157,894$5,999,999→ 3,157,894 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 3,015,545(indirect: By: Vivo Capital Fund IX, L.P.)
Common Stock
Footnotes (3)
- [F1]Purchase was made pursuant to that certain Securities Purchase Agreement dated as of August 7, 2023, by and among the Issuer and the purchasers named therein.
- [F2]The securities are held directly by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As the managing members of Vivo Opportunity, LLC, Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang share voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P., but each disclaims beneficial ownership of such securities except to the extent of their individual pecuniary interest therein.
- [F3]These warrants expire at 5:00 p.m. on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023, provided that the holder will be prohibited from exercising these warrants if, after giving effect to such exercise, the holder (together with such holder's affiliates and any other persons acting as a group together) would beneficially own in excess of 9.99% of the shares of common stock of the Issuer outstanding immediately after giving effect to such exercise.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001728970
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 9:03 AM ET
- Size
- 14.6 KB